Stocks Higher as In...
Health Care: Drugs
Neptune Technologies & Bioressources Inc. (NEPT: NASDAQ)
$2.98 -0.02 | -0.67%
06/18/13 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 3.00 |
| 52 Week High | 5.14 |
| 52 Week Low | 1.62 |
| Avg. Daily Vol. (Mil) | 0.23 |
| Beta (3 year) | 2.71 |
| Share Related Items | |
| Mkt Cap (Mil) | 180.33 |
| Shares Out (Mil) | 60.11 |
| Float (Mil) | 26.55 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.30 |
| Current Ratio | 5.70 |
| LT Debt/ Equity | 0.03 |
| Total Debt / Equity | 0.03 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 7.14 |
| Price/Book | 3.28 |
| Price/Cash Flow | -9.50 |
| Per Share Data | |
| Earnings | -0.30 |
| Sales | 0.42 |
| Book Value | 0.91 |
| Cash Flow | -0.31 |
| Business Summary | |
|---|---|
| Neptune Technologies & Bioressources Inc. is a biotechnology company engaged in the development, manufacture and commercialization of marinederived omega3 polyunsaturated fatty acids. | |
| General Information | |
| 545 Promenade du Centropolis
Suite 100 Laval, QC H7T 0A3 |
|
| www.neptunebiotech.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 51 | |
| CEO: Henri Harland | |
| Short Interest | |
| Current Month (Mil) | 1.61 |
| Previous Month (Mil) | 1.64 |
| Short Interest Ratio (Days) | 5.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -29.60 |
| Return on Investments | -34.00 |
| Profitability | |
| Gross Margin | 41.90 |
| EBIT Margin | -71.80 |
| Profit Margin | -77.20 |
Portfolios with NEPT
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- UserCurent Holdings
- Usertest
- ContributorBreakout Stocks Of The Week...
- Usersuziltd
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Cheap Biotech Stocks Tha...
- UserMock Cash Builder
Latest NEPT Headlines from TheStreet
- Neptune Commences Reconstruction Of Sherbrooke Plant 05.28.13 | 08:05 am
- CORRECTION FROM SOURCE: Neptune Reports Fiscal 2013 Results And Provides Update On Action Plan To Resume Operations 05.22.13 | 11:05 am
- Neptune Reports Fiscal 2013 Results And Provides Update On Action Plan To Resume Operations 05.22.13 | 08:05 am
- Neptune Responds To Aker's Continued Attempts To Deflect Attention From Its Sustained Patent Infringement 05.15.13 | 08:05 am
- Class Action Lawsuit Against Neptune Dismissed 05.15.13 | 08:05 am
- Neptune To Hold Conference Call To Discuss Fourth Quarter And Fiscal 2013 Results 05.09.13 | 08:05 am
- 5 Stocks Under $10 Set to Surge 05.02.13 | 02:05 pm
- The U.S. International Trade Commission (ITC) Votes To Institute Patent Infringements Investigation Based On Neptune & Acasti Complaint 04.15.13 | 08:04 am
- Neptune Provides Update On European Patent Dispute And Maintains Its International Patent Strategy 04.10.13 | 10:04 am
- Neptune To Present At The Annual ROTH Conference 03.14.13 | 08:03 am
Press Releases for NEPT
- Pittsburgh Law Office Of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf Of Shareholders Of Groupon (GRPN) And Announces Investigations Of Diodes (DIOD), Hemispherex Biopharma (HEB), ISIS Pharmaceuticals (ISIS), K-Swiss (KSWS), MAP Pharmaceuticals (MAPP), Neptune Technologies & Bioressources (NEPT), SeaCube Container Leasing (BOX), Spirit AeroSystems Holdings (SPR), Verisign (VRSN), And Yum! Brands (YUM) - PR Newswire 01.23.13 | 03:01 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Neptune Technologies & Bioressources Inc. To Contact The Firm - PR Newswire 01.19.13 | 10:01 am
- Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Neptune Technologies & Bioresources Inc. - PR Newswire 01.07.13 | 08:01 am
- Robbins Umeda LLP Announces The Filing Of A Securities Fraud Class Action Lawsuit Against Neptune Technologies & Bioressources Inc. - PR Newswire 12.21.12 | 09:12 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Neptune Technologies & Bioressources Inc. To Contact The Firm - PR Newswire 12.21.12 | 09:12 pm
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Neptune Technologies & Bioresources Inc. - Business Wire 12.20.12 | 06:12 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Neptune Technologies & Bioressources Inc. - Business Wire 12.19.12 | 05:12 pm
Partner Headlines for NEPT
- Do You Have The Guts To Take On Cutting-Edge Biotech Like This VC? - Seeking Alpha 12.14.12 | 09:12 am
- Morning Market Losers - Benzinga 11.27.12 | 09:11 am
- The Future For Treating High Triglycerides: Krill Oil Neptune Style - Seeking Alpha 07.05.12 | 09:07 am
- Corinthian Colleges and 2 NASDAQ Top Percentage Winners - Wall St. Cheat Sheet 05.29.12 | 09:05 am
- Amarin: Most Undervalued Name In Biotech? - Seeking Alpha 05.13.12 | 08:05 am
- Neptune: Going All Out For The Krill With Its NKO Punch - Seeking Alpha 04.04.12 | 08:04 am
- With Neptune, Opportunity Is Knockin' - Seeking Alpha 03.19.12 | 09:03 am
- Whether Neptune Can Overcome Market Weigh-Down And Deliver On Milestones - Seeking Alpha 09.28.11 | 08:09 am
- Neptune Has Moved Beyond Downward Catalysts - Seeking Alpha 09.16.11 | 09:09 am
- Analyst Predicts Demand and Production Output Will Push Neptune Technologies' Price - Seeking Alpha 05.18.11 | 09:05 am
